Moreover, knockdown of RRM2 inhibited HBV replication and RRM2 inhibitors (e.g., Pterostilbene) suppressed HBV replication and hepatocellular carcinoma proliferation [34,35]. The gene discussed is RRM2; the disease is hepatocellular carcinoma.